Valuation: China Isotope & Radiation Corporation

Market Cap 486.49Cr 561.7Cr 72Cr 63Cr 57Cr 54Cr 101.6Cr 6.82TCr 103.31Cr 691.93Cr 268.16Cr 3.34TCr 268.92Cr 263.08Cr 12TCr P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 498.37Cr 575.42Cr 73Cr 64Cr 59Cr 55Cr 104.08Cr 6.98TCr 105.84Cr 708.83Cr 274.71Cr 3.43TCr 275.49Cr 269.5Cr 12TCr EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
18/06 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
18/06 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
27/05 China Isotope Proposes Auditor Change MT
26/05 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
27/03 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
27/03 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
27/03 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
19/03 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
14/03 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
13/03 China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality RE
02/03 China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer MT
12/02 China Isotope & Radiation Warns of Up to 25% Lower 2025 Profit MT
12/02 China Isotope & Radiation Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025 CI
1 day+1.68%
1 week-0.90%
Current month+0.34%
1 month-6.15%
3 months-12.20%
6 months-17.94%
Current year-13.07%
1 week 17.12
Extreme 17.12
18.7
1 month 17.02
Extreme 17.02
20.22
Current year 17.02
Extreme 17.02
24.28
1 year 14.28
Extreme 14.28
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
32.1
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 55 02/08/2024
Corporate Secretary - 30/08/2024
Corporate Secretary - 30/08/2024
Director TitleAgeSince
Director/Board Member 64 30/06/2023
Director/Board Member 46 25/02/2021
Director/Board Member 57 22/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.68%-0.90%+15.53%+14.62% 70Cr
-1.63%+17.52%+234.75%+369.22% 2.23TCr
-1.27%-3.09%-41.97%-26.21% 953.03Cr
-11.56%+0.81%+38.02%+30.95% 715.45Cr
-2.40%-2.14%-31.51% - 517.31Cr
+0.23%+4.04%-20.04%-24.92% 511.27Cr
-0.10%+9.18%+199.85%-30.14% 495.26Cr
-1.07%-7.50%+82.28%+88.70% 413.74Cr
+0.61%+2.11%-22.76%-25.45% 420.83Cr
+2.89%+4.80%-17.15%-40.03% 253.64Cr
Average -0.12%+2.82%+43.70%+39.64% 657.84Cr
Weighted average by Cap. -0.86%+5.24%+91.78%+133.44%

Financials

2024 2025
Net sales 757.48Cr 874.58Cr 111.51Cr 97Cr 89Cr 83Cr 158.19Cr 11TCr 160.86Cr 1.08TCr 417.52Cr 5.21TCr 418.72Cr 409.62Cr 18TCr 718.77Cr 829.88Cr 105.82Cr 92Cr 85Cr 79Cr 150.11Cr 10TCr 152.64Cr 1.02TCr 396.19Cr 4.94TCr 397.32Cr 388.68Cr 17TCr
Net income 41Cr 47Cr 5.99Cr 5.23Cr 4.8Cr 4.48Cr 8.49Cr 569.93Cr 8.64Cr 58Cr 22Cr 279.54Cr 22Cr 22Cr 963.22Cr 33Cr 38Cr 4.82Cr 4.21Cr 3.87Cr 3.61Cr 6.84Cr 458.9Cr 6.95Cr 47Cr 18Cr 225.08Cr 18Cr 18Cr 775.57Cr
Net Debt -11Cr -13Cr -1.6Cr -1.4Cr -1.29Cr -1.2Cr -2.27Cr -152.67Cr -2.31Cr -15Cr -6Cr -75Cr -6.02Cr -5.89Cr -258.03Cr 12Cr 14Cr 1.75Cr 1.53Cr 1.4Cr 1.31Cr 2.48Cr 166.56Cr 2.52Cr 17Cr 6.55Cr 82Cr 6.57Cr 6.43Cr 281.5Cr
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
03/26/03 HK$17.56 +1.68% 92,800
02/26/02 HK$17.27 -1.31% 34,800
30/26/30 HK$17.50 +0.40% 18,400
29/26/29 HK$17.43 +0.75% 91,000
26/26/26 HK$17.30 -2.37% 66,600

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock